Axsome drug succeeds in narcolepsy symptoms trial
26 Mar 2024 //
BIOPHARMADIVE
Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc.
13 Jan 2020 //
GLOBENEWSWIRE
Axsome Therapeutics Completes Patient Enrollment in the CONCERT Phase 2 Trial
21 Oct 2019 //
BIOSPACE
Axsome completes patient enrollment in CONCERT ph2 trial of AXS-12 in narcolepsy
21 Oct 2019 //
PHARMABIZ